With one med available and others coming soon, patients have more options than ever for near vision correction. Do they offer enough to make a difference in a well-established market?
It’s an exciting time for optometrists prescribing therapeutics. A number of blockbuster topical ophthalmic drugs should become available within a year and can potentially make a big impact for you and your patients. We’ll revisit a few significant recent approvals along with what’s on the horizon.
Proceedings of the 20th Annual Meeting of the Optometric Glaucoma Society. Read about how to detect glaucoma in high myopes, the effect of smoking on myopia and IOP-independent glaucoma treatments.Sponsored by Bausch + Lomb
Women In Optometry continues to be published online, with regular updates on practice design, practice success, news, trends and perspectives. Visit womeninoptometry.com.